Movers & shakers
US biotechnology company Altavant Sciences, which focuses on drug development for rare respiratory diseases, has appointed Howard M. Lazarus as CMO. Lazarus has over 20 years’ experience in drug development for pulmonary, vascular and interstitial diseases.
Nature’s nanoworld
Life operates on the nanometre scale. The fundamental processes of muscle action, reproduction, genetic inheritance, metabolism, and everything else that living things do, are what we now call ‘nano’. They are carried out by macromolecules within or near cells, with dimensions and distances measuring a few nanometres at most.
Fixing the results
This book, originally published in France, investigates this growing international problem, its causes, and argues that recent developments can explain why fraudulent behaviour has become so prevalent.
Welding the impossible
Welding, in some form or another, has been used since ancient times. Now, detailed research into the underlying processes could help extend the technique even further.
Managing a winning LIMS team
Christine Paszko and Laura Lee Williford, from Accelerated Technologies, highlight the importance of project managers and the key management requirements when implementing informatics systems
Fresh air
From filter systems to car-free cities, scientists and thinkers have different visions for tackling air pollution, the biggest environmental health risk in the world.
Business digest
Global pharma major AstraZeneca is collaborating with UK biotechnology company Silence Therapeutics to discover, develop and commercialise small interfering RNA (siRNA) therapeutics for cardiovascular, renal, metabolic and respiratory diseases.
Coronavirus update from SCI
In these exceptional times our priorities are the welfare of members, staff and our community, continuity of services to ensure our community continues to work through this next period, and to support any government responses to the Covid-19 outbreak.
Electronic tattoos
The market for personal health monitoring – including consumer electronics such as wristwatches – is estimated to reach $67.98bn by the end of 2022. But could electronic tattoos on skin be the next design breakthrough?
RNA vaccine printer
A German biopharma company is building an RNA printer to speedily generate emergency vaccines against future pandemics. The printer would be swiftly dispatched to the location of an outbreaks to make and dispense vaccine.